Sabyasachi Moulik, Ph.D.

Sabyasachi Moulik, Ph.D., is primarily involved in teaching physiology and pathophysiology in the first two years of the M.D. curriculum. Moulik is experienced in teaching physiology and pathophysiology and was previously chair of the premedical department at the Medical University of the Americas, Charlestown, Nevis. 

He is a member of Sigma Xi, Scientific Research Society; the American Society for Cell Biology; and the American Physiological Society.

Education 

Ph.D., Biomedical Sciences, General, East Tennessee State University, TN 
M.S., Biomedical Sciences, East Tennessee State University, TN 
M.Sc., Biophysics, Panjab University, India 
B.Sc., Biophysics, Panjab University, India 

Areas of interest/specialization

Moulik’s interest is in endocrinology and medical education. He strives to create an atmosphere of inclusiveness and uses a variety of active learning strategies into his teaching. As a course director and participating faculty in preclinical courses, Moulik incorporates interactive lectures, small and large-group case-based learning, team-based learning, evidence-based medicine activities, game-based learning, and ‘Meet the Patient’ sessions to stimulate student learning.  

Awards

FIU Senate ‘Faculty Award for Excellence in Teaching, 2020 
HWCOM’s Excellence in Teaching Award for ‘Lecturing and Course Direction, 2019 
Outstanding Professor Award- in Recognition of Superior Teaching and Commitment to Quality Medical Education, Medical University of the Americas, Charleston, Nevis 

Selected publications  

1. Nguyen KH, Yao XH, Moulik S, Mishra S, and Nyomba G. (2011). Human IGF Binding Protein-3 Overexpression Impairs Glucose Regulation in Mice Via an Inhibition of Insulin Secretion. Endocrinology. 152(6):2184-2196. 
2. Ande S, Moulik S, and Mishra S. (2009). Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: Implication for a novel binary switch. PLoS ONE. 4(2): e4586.  
3. Mishra S,* Moulik S,* and Murphy LJ. (2007). Prohibitin binds to C3 and enhances complement activation. Mol. Immunol. 44(8): 1897-1902 (*equal contributors).  
4. Vessal M, Mishra S, Moulik S, and Murphy LJ. (2006). Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J. 273 (3): 568-576. 
5. Moulik S, Speth RC, Turner BB, and Rowe BP. (2002). Angiotensin II receptor subtype distribution in the rabbit brain. Exp. Brain Res.,142 (2): 275-283. 

View more publications